Logo image of DRD

DRDGOLD LTD-SPONSORED ADR (DRD) Stock Fundamental Analysis

NYSE:DRD - New York Stock Exchange, Inc. - US26152H3012 - ADR - Currency: USD

15.16  -0.13 (-0.85%)

After market: 15.25 +0.09 (+0.59%)

Fundamental Rating

7

Overall DRD gets a fundamental rating of 7 out of 10. We evaluated DRD against 156 industry peers in the Metals & Mining industry. While DRD has a great profitability rating, there are some minor concerns on its financial health. DRD is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year DRD was profitable.
In the past year DRD had a positive cash flow from operations.
DRD had positive earnings in each of the past 5 years.
In the past 5 years DRD always reported a positive cash flow from operatings.
DRD Yearly Net Income VS EBIT VS OCF VS FCFDRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B 1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 16.57%, DRD belongs to the top of the industry, outperforming 95.51% of the companies in the same industry.
DRD's Return On Equity of 22.26% is amongst the best of the industry. DRD outperforms 92.31% of its industry peers.
DRD's Return On Invested Capital of 16.79% is amongst the best of the industry. DRD outperforms 95.51% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DRD is in line with the industry average of 12.32%.
The 3 year average ROIC (14.11%) for DRD is below the current ROIC(16.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.57%
ROE 22.26%
ROIC 16.79%
ROA(3y)15.22%
ROA(5y)15.9%
ROE(3y)20.12%
ROE(5y)21.19%
ROIC(3y)14.11%
ROIC(5y)15.97%
DRD Yearly ROA, ROE, ROICDRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

DRD's Profit Margin of 24.19% is amongst the best of the industry. DRD outperforms 90.38% of its industry peers.
DRD's Profit Margin has improved in the last couple of years.
The Operating Margin of DRD (30.64%) is better than 83.97% of its industry peers.
In the last couple of years the Operating Margin of DRD has grown nicely.
With a decent Gross Margin value of 33.38%, DRD is doing good in the industry, outperforming 75.00% of the companies in the same industry.
DRD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 30.64%
PM (TTM) 24.19%
GM 33.38%
OM growth 3Y-9.2%
OM growth 5Y41.5%
PM growth 3Y-7.98%
PM growth 5Y49.6%
GM growth 3Y-6.69%
GM growth 5Y30.15%
DRD Yearly Profit, Operating, Gross MarginsDRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

DRD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DRD has about the same amount of shares outstanding.
Compared to 5 years ago, DRD has more shares outstanding
DRD has a better debt/assets ratio than last year.
DRD Yearly Shares OutstandingDRD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DRD Yearly Total Debt VS Total AssetsDRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

A Debt/Equity ratio of 0.00 indicates that DRD is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, DRD belongs to the best of the industry, outperforming 80.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.04
WACC16.12%
DRD Yearly LT Debt VS Equity VS FCFDRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

DRD has a Current Ratio of 2.34. This indicates that DRD is financially healthy and has no problem in meeting its short term obligations.
DRD has a Current ratio of 2.34. This is comparable to the rest of the industry: DRD outperforms 48.72% of its industry peers.
DRD has a Quick Ratio of 1.63. This is a normal value and indicates that DRD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.63, DRD is in line with its industry, outperforming 50.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 1.63
DRD Yearly Current Assets VS Current LiabilitesDRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.36% over the past year.
The Earnings Per Share has been growing by 67.77% on average over the past years. This is a very strong growth
The Revenue has grown by 21.52% in the past year. This is a very strong growth!
DRD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.70% yearly.
EPS 1Y (TTM)28.36%
EPS 3Y-2.81%
EPS 5Y67.77%
EPS Q2Q%64.61%
Revenue 1Y (TTM)21.52%
Revenue growth 3Y5.8%
Revenue growth 5Y17.7%
Sales Q2Q%27.84%

3.2 Future

Based on estimates for the next years, DRD will show a very strong growth in Earnings Per Share. The EPS will grow by 29.31% on average per year.
The Revenue is expected to grow by 14.84% on average over the next years. This is quite good.
EPS Next Y20.31%
EPS Next 2Y22.2%
EPS Next 3Y29.31%
EPS Next 5YN/A
Revenue Next Year24.58%
Revenue Next 2Y15.56%
Revenue Next 3Y14.84%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DRD Yearly Revenue VS EstimatesDRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
DRD Yearly EPS VS EstimatesDRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

DRD is valuated correctly with a Price/Earnings ratio of 13.54.
Compared to the rest of the industry, the Price/Earnings ratio of DRD indicates a rather cheap valuation: DRD is cheaper than 87.82% of the companies listed in the same industry.
DRD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.41.
DRD is valuated reasonably with a Price/Forward Earnings ratio of 11.75.
DRD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DRD is cheaper than 71.79% of the companies in the same industry.
DRD is valuated cheaply when we compare the Price/Forward Earnings ratio to 33.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.54
Fwd PE 11.75
DRD Price Earnings VS Forward Price EarningsDRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRD Per share dataDRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of DRD may justify a higher PE ratio.
DRD's earnings are expected to grow with 29.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.67
PEG (5Y)0.2
EPS Next 2Y22.2%
EPS Next 3Y29.31%

More info and screens

4

5. Dividend

5.1 Amount

DRD has a Yearly Dividend Yield of 1.76%.
Compared to an average industry Dividend Yield of 2.85, DRD pays a better dividend. On top of this DRD pays more dividend than 82.05% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.39, DRD is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.76%

5.2 History

DRD has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DRD Yearly Dividends per shareDRD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

20.16% of the earnings are spent on dividend by DRD. This is a low number and sustainable payout ratio.
DP20.16%
EPS Next 2Y22.2%
EPS Next 3Y29.31%
DRD Yearly Income VS Free CF VS DividendDRD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B
DRD Dividend Payout.DRD Dividend Payout, showing the Payout Ratio.DRD Dividend Payout.PayoutRetained Earnings

More info and screens

DRDGOLD LTD-SPONSORED ADR

NYSE:DRD (8/11/2025, 8:27:35 PM)

After market: 15.25 +0.09 (+0.59%)

15.16

-0.13 (-0.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-18 2025-02-18/bmo
Earnings (Next)08-20 2025-08-20/bmo
Inst Owners15.02%
Inst Owner Change3.46%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.31B
Analysts42.5
Price Target16.03 (5.74%)
Short Float %3.79%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield 1.76%
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP20.16%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-14 2025-03-14 (0.165399)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.2%
PT rev (3m)36.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.47%
Revenue NY rev (3m)3.47%
Valuation
Industry RankSector Rank
PE 13.54
Fwd PE 11.75
P/S 3.28
P/FCF N/A
P/OCF 9.68
P/B 3.01
P/tB 3.01
EV/EBITDA N/A
EPS(TTM)1.12
EY7.39%
EPS(NY)1.29
Fwd EY8.51%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)1.57
OCFY10.33%
SpS4.63
BVpS5.03
TBVpS5.03
PEG (NY)0.67
PEG (5Y)0.2
Profitability
Industry RankSector Rank
ROA 16.57%
ROE 22.26%
ROCE 22.53%
ROIC 16.79%
ROICexc 18.04%
ROICexgc 18.04%
OM 30.64%
PM (TTM) 24.19%
GM 33.38%
FCFM N/A
ROA(3y)15.22%
ROA(5y)15.9%
ROE(3y)20.12%
ROE(5y)21.19%
ROIC(3y)14.11%
ROIC(5y)15.97%
ROICexc(3y)19.7%
ROICexc(5y)23.63%
ROICexgc(3y)19.7%
ROICexgc(5y)23.63%
ROCE(3y)18.93%
ROCE(5y)21.41%
ROICexcg growth 3Y-26.45%
ROICexcg growth 5Y39.34%
ROICexc growth 3Y-26.45%
ROICexc growth 5Y39.34%
OM growth 3Y-9.2%
OM growth 5Y41.5%
PM growth 3Y-7.98%
PM growth 5Y49.6%
GM growth 3Y-6.69%
GM growth 5Y30.15%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 40.45%
Interest Coverage 349.27
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 1.63
Altman-Z N/A
F-Score6
WACC16.12%
ROIC/WACC1.04
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)26.7%
Cap/Sales(5y)18.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.36%
EPS 3Y-2.81%
EPS 5Y67.77%
EPS Q2Q%64.61%
EPS Next Y20.31%
EPS Next 2Y22.2%
EPS Next 3Y29.31%
EPS Next 5YN/A
Revenue 1Y (TTM)21.52%
Revenue growth 3Y5.8%
Revenue growth 5Y17.7%
Sales Q2Q%27.84%
Revenue Next Year24.58%
Revenue Next 2Y15.56%
Revenue Next 3Y14.84%
Revenue Next 5YN/A
EBIT growth 1Y44.9%
EBIT growth 3Y-3.93%
EBIT growth 5Y66.55%
EBIT Next Year0.79%
EBIT Next 3Y17.97%
EBIT Next 5YN/A
FCF growth 1Y-163.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.39%
OCF growth 3Y5.46%
OCF growth 5Y44.96%